‘Tuesday Night Lecture Series’ Course Offerings for June

Radiotherapy Clinics of Georgia (RCOG), a division of Radiotherapy Clinics of Georgia, has announced the details of their Tuesday Night Lecture Series courses to be presented in June. The courses enable consumers to become better educated about their health and learn more about the latest in radiation therapy options.

All Tuesday Night Lecture Series courses are offered free to the public and begin with a light dinner at 5 p.m. followed by a lecture beginning at 5:30 p.m. Classes are presented at the Radiotherapy Clinics of Georgia Auditorium located at 2339 Lawrenceville Highway, Decatur, GA 30033.

For more information on the Tuesday Night Lecture Series or to RSVP for a specific class, please call 404-633-5606, ext. 320.

Tuesday Night Lecture Series include:

Tuesday, June 1, 5:30 p.m.

“PSA Bounce” – Philip Shrake, M.D., explains the temporary benign rise in prostate-specific antigens (PSA), a protein produced by the cells of the prostate gland which can be used to detect prostate cancer.

Tuesday, June 8, 5:30 p.m.

“Image-Guided Radiation Therapy” – Mark L. Merlin, M.D., presents an in-depth explanation of the image-guided treatment setup used in radiation therapy.

Tuesday, June 15, 5:30 p.m.

“RCOG Database” – Chad Levitt, M.D., shares information about the treatment database, containing information about 12,500 men who have been treated for prostate cancer. The database, one of the most comprehensive in the nation, enables men and their physicians to determine the prostate cancer treatment method that gives them the best chance of a cure.

Tuesday, June 22, 5:30 p.m.

“Q&A on PSA and Gleason Scores” – Gary Stillwagon, M.D., coordinates an open discussion on the importance of prostate-specific antigen (PSA) screening, Gleason scoring and the differences between clinical and pathologic staging.

Tuesday, June 29, 5:30 p.m.

“The History of ProstRcision” – Frank Critz, M.D., will discuss ProstRcision®, a unique technique for curing prostate cancer that has the industry’s highest documented cure rate of 83 percent. He will shed light on the original procedure and its development through the years.